Aleve Ad
This article was originally published in The Tan Sheet
Executive Summary
Bayer stresses the importance of reading the label in a new AleveTV spot that broke Jan. 14. The ad depicts a daughter concerned about her mother's use of Aleve for arthritis. The mother responds: "I checked with my doctor [and] he said Aleve is fine for me. Just follow the directions on the label." The ad comes on the heels of a recently halted study that linked naproxen to an increased risk of cardiovascular events (1"The Tan Sheet" Jan. 3, 2005, p. 3)...
You may also be interested in...
Naproxen Heart Concerns Surface In Halted NIH Alzheimer’s Trial
The OTC industry is taking a wait-and-see approach regarding concerns about cardiovascular risks of naproxen (Bayer's Aleve) and other older NSAIDs rising in the wake of COX-2-related safety issues
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.